Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center

By: Newsfile

Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas healthcare is experiencing a historic breakthrough with the approval of House Bill 46 (HB 46). Signed into law on June 21, 2025, by Governor Greg Abbott, the expansion of the Texas Compassionate Use Program (TCUP) will cover chronic pain, PTSD, and degenerative neurological conditions, among others, and will directly benefit more than one million Texans, including 300,000 veterans. The law also updates permissible cannabinoid concentrations, signaling a decisive step toward integrating cannabis-based therapies into clinical practice.

The Statewide Educational Seminar Series will take place in key cities: UTHealth Houston — November 15, 2025; Austin, TX — December 6, 2025; Dallas, TX — January 17, 2026; El Paso, TX — February 21, 2026. Sessions will address patient registration, prescriber responsibilities, regulatory and liability considerations, reimbursement pathways, and the latest evidence in cannabinoid science.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1_550.jpg

Figure 1

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1.jpg

CBIH is also entering a stage of accelerated growth driven by key factors such as cannabis tax reductions in California, the expansion of legislation in Texas, regulatory updates in Delaware, and progress toward banking reform. These developments directly strengthen the company's revenue outlook and reinforce its market position. Jennifer Salguero Ph.D. in Sciences noted that the cannabis industry is moving toward unprecedented financial stability, creating a unique opportunity for CBIH to increase its revenue streams, expand its educational/research programs, and deliver sustained value to CBIH revenue-generating centers.

"This is a transformative milestone for medical cannabis in Texas," said Rosangel Andrades, M.D., CBIH Director of R&D. "Participants will not only stay informed-they will help shape patient care, professional practice, and the scientific agenda ahead."

Cannabis Bioscience International Holdings is a global leader in cannabis research and education, with a track record of government-authorized training partnership in Puerto Rico and six years of accredited programs across six universities in Colombia. CBIH's library includes 150+ instructional videos and 250+ eBooks and audiobooks in seven languages, equipping professionals to integrate cannabis therapies safely and scientifically.

For the agenda, speaker bios and abstracts — Julian González, M.D. (Clinical Medicine), and Brian Cuban, Esq. (Legal Perspectives / Law & Professional Well-Being) — as well as ongoing updates, please visit the event webpage: www.vitabiotechresearch.com. This is a watershed moment for healthcare in Texas-one that reflects a shared commitment to science, safety, and patient dignity, and that sets the stage for evidence-based practice, responsible policy, and improved patient outcomes in the years ahead.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.

For more information contact us at:

(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268301

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.